Concepedia

Srinath Thirumalairajan

ST

4

Publications

109

Citations

4

H-Index

2005

Active since

Affiliations

Seagen (United States)(Current)

Srinath Thirumalairajan is an author at Seagen (United States) specializing in medicine, drug discovery, and natural sciences.

ORCID

Top concepts

Publications per year

2005–2023

4

Publications

4

The first de novo designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase

T. Heikkila, Srinath Thirumalairajan, Matthew Davies et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 63 citations · Full text

, , +7

Rational design and synthesis of substrate–product analogue inhibitors of α-methylacyl-coenzyme A racemase from Mycobacterium tuberculosis

Mohan Pal, Mandar Khanal, Ryan Marko et al. · Chemical Communications · 2015 · 20 citations

, , +15

Development of a Single-Step Antibody–Drug Conjugate Purification Process with Membrane Chromatography

Juan Carlos Cordova, Sheng Sun, Jeffrey Bos et al. · Journal of Clinical Medicine · 2021 · 13 citations · Full text

Drug-Linkers in Antibody–Drug Conjugates: Perspective on Current Industry Practices

Paul G. Bulger, David A. Conlon, Russell D. Cink et al. · Organic Process Research & Development · 2023 · 13 citations

, , +19

Rows per page

1–4 of 4